CFO exercised or converted 80K CORT derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jul 30, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Aug 4, 2026
CFOOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001193125-26-330668
- Filed / recorded
Added to OQROOct 6, 2026, 7:14 PM UTC Data qualityVerified: identifiers matched exactly IssuerCORCEPT THERAPEUTICS INC Reporting personAtabak Mokari Officer titleChief Financial Officer SecurityStock option (right to buy) TableDerivative (Table II) Transaction dateJul 30, 2026 Acquired / disposedDisposed (D) Footnotes from the filing
- Fully exercisable.
Around the same time
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
A board member of Corcept Therapeutics sold $3.27M of Corcept Therapeutics shares. Nobody planned it ahead of time.